Global Molecular Theranostics Supply, Demand and Key Producers, 2023-2029

May 2023 | 112 pages | ID: GC4533D68CBEEN
GlobalInfoResearch

Abstracts

The global Molecular Theranostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Molecular theranostics can be described as a system that integrates a diagnostic test with a therapeutic intervention targeting a molecular feature of disease.

This report studies the global Molecular Theranostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Molecular Theranostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Theranostics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Molecular Theranostics total market, 2018-2029, (USD Million)

Global Molecular Theranostics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Molecular Theranostics total market, key domestic companies and share, (USD Million)

Global Molecular Theranostics revenue by player and market share 2018-2023, (USD Million)

Global Molecular Theranostics total market by Type, CAGR, 2018-2029, (USD Million)

Global Molecular Theranostics total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Molecular Theranostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark and Siemens Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Theranostics market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Molecular Theranostics Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Molecular Theranostics Market, Segmentation by Type

• Amplification Theranostics
• Amplified Gene Detection Theranostics
• Oligonucleotide Microarrays
• Gene Sequencing

Global Molecular Theranostics Market, Segmentation by Application

• Hospitals and Clinics
• Research Institutes
• Diagnostic Centers
• Others

Companies Profiled:

• Roche
• Abbott
• BD
• Biomerieux
• Qiagen
• Thermo Fisher Scientific
• Agilent
• GenMark
• Siemens Healthcare
• AutoGenomics

Key Questions Answered

1. How big is the global Molecular Theranostics market?

2. What is the demand of the global Molecular Theranostics market?

3. What is the year over year growth of the global Molecular Theranostics market?

4. What is the total value of the global Molecular Theranostics market?

5. Who are the major players in the global Molecular Theranostics market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Molecular Theranostics Introduction
1.2 World Molecular Theranostics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Theranostics Total Market by Region (by Headquarter Location)
  1.3.1 World Molecular Theranostics Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Molecular Theranostics Market Size (2018-2029)
  1.3.3 China Molecular Theranostics Market Size (2018-2029)
  1.3.4 Europe Molecular Theranostics Market Size (2018-2029)
  1.3.5 Japan Molecular Theranostics Market Size (2018-2029)
  1.3.6 South Korea Molecular Theranostics Market Size (2018-2029)
  1.3.7 ASEAN Molecular Theranostics Market Size (2018-2029)
  1.3.8 India Molecular Theranostics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Molecular Theranostics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Molecular Theranostics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Molecular Theranostics Consumption Value (2018-2029)
2.2 World Molecular Theranostics Consumption Value by Region
  2.2.1 World Molecular Theranostics Consumption Value by Region (2018-2023)
  2.2.2 World Molecular Theranostics Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Theranostics Consumption Value (2018-2029)
2.4 China Molecular Theranostics Consumption Value (2018-2029)
2.5 Europe Molecular Theranostics Consumption Value (2018-2029)
2.6 Japan Molecular Theranostics Consumption Value (2018-2029)
2.7 South Korea Molecular Theranostics Consumption Value (2018-2029)
2.8 ASEAN Molecular Theranostics Consumption Value (2018-2029)
2.9 India Molecular Theranostics Consumption Value (2018-2029)

3 WORLD MOLECULAR THERANOSTICS COMPANIES COMPETITIVE ANALYSIS

3.1 World Molecular Theranostics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Molecular Theranostics Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Molecular Theranostics in 2022
  3.2.3 Global Concentration Ratios (CR8) for Molecular Theranostics in 2022
3.3 Molecular Theranostics Company Evaluation Quadrant
3.4 Molecular Theranostics Market: Overall Company Footprint Analysis
  3.4.1 Molecular Theranostics Market: Region Footprint
  3.4.2 Molecular Theranostics Market: Company Product Type Footprint
  3.4.3 Molecular Theranostics Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Molecular Theranostics Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Molecular Theranostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Molecular Theranostics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Theranostics Consumption Value Comparison
  4.2.1 United States VS China: Molecular Theranostics Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Molecular Theranostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Theranostics Companies and Market Share, 2018-2023
  4.3.1 United States Based Molecular Theranostics Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Molecular Theranostics Revenue, (2018-2023)
4.4 China Based Companies Molecular Theranostics Revenue and Market Share, 2018-2023
  4.4.1 China Based Molecular Theranostics Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Molecular Theranostics Revenue, (2018-2023)
4.5 Rest of World Based Molecular Theranostics Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Molecular Theranostics Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Molecular Theranostics Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Molecular Theranostics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Amplification Theranostics
  5.2.2 Amplified Gene Detection Theranostics
  5.2.3 Oligonucleotide Microarrays
  5.2.4 Gene Sequencing
5.3 Market Segment by Type
  5.3.1 World Molecular Theranostics Market Size by Type (2018-2023)
  5.3.2 World Molecular Theranostics Market Size by Type (2024-2029)
  5.3.3 World Molecular Theranostics Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Molecular Theranostics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals and Clinics
  6.2.2 Research Institutes
  6.2.3 Diagnostic Centers
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Molecular Theranostics Market Size by Application (2018-2023)
  6.3.2 World Molecular Theranostics Market Size by Application (2024-2029)
  6.3.3 World Molecular Theranostics Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Roche
  7.1.1 Roche Details
  7.1.2 Roche Major Business
  7.1.3 Roche Molecular Theranostics Product and Services
  7.1.4 Roche Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Roche Recent Developments/Updates
  7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
  7.2.1 Abbott Details
  7.2.2 Abbott Major Business
  7.2.3 Abbott Molecular Theranostics Product and Services
  7.2.4 Abbott Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Abbott Recent Developments/Updates
  7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BD
  7.3.1 BD Details
  7.3.2 BD Major Business
  7.3.3 BD Molecular Theranostics Product and Services
  7.3.4 BD Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 BD Recent Developments/Updates
  7.3.6 BD Competitive Strengths & Weaknesses
7.4 Biomerieux
  7.4.1 Biomerieux Details
  7.4.2 Biomerieux Major Business
  7.4.3 Biomerieux Molecular Theranostics Product and Services
  7.4.4 Biomerieux Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Biomerieux Recent Developments/Updates
  7.4.6 Biomerieux Competitive Strengths & Weaknesses
7.5 Qiagen
  7.5.1 Qiagen Details
  7.5.2 Qiagen Major Business
  7.5.3 Qiagen Molecular Theranostics Product and Services
  7.5.4 Qiagen Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Qiagen Recent Developments/Updates
  7.5.6 Qiagen Competitive Strengths & Weaknesses
7.6 Thermo Fisher Scientific
  7.6.1 Thermo Fisher Scientific Details
  7.6.2 Thermo Fisher Scientific Major Business
  7.6.3 Thermo Fisher Scientific Molecular Theranostics Product and Services
  7.6.4 Thermo Fisher Scientific Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Thermo Fisher Scientific Recent Developments/Updates
  7.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.7 Agilent
  7.7.1 Agilent Details
  7.7.2 Agilent Major Business
  7.7.3 Agilent Molecular Theranostics Product and Services
  7.7.4 Agilent Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Agilent Recent Developments/Updates
  7.7.6 Agilent Competitive Strengths & Weaknesses
7.8 GenMark
  7.8.1 GenMark Details
  7.8.2 GenMark Major Business
  7.8.3 GenMark Molecular Theranostics Product and Services
  7.8.4 GenMark Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 GenMark Recent Developments/Updates
  7.8.6 GenMark Competitive Strengths & Weaknesses
7.9 Siemens Healthcare
  7.9.1 Siemens Healthcare Details
  7.9.2 Siemens Healthcare Major Business
  7.9.3 Siemens Healthcare Molecular Theranostics Product and Services
  7.9.4 Siemens Healthcare Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Siemens Healthcare Recent Developments/Updates
  7.9.6 Siemens Healthcare Competitive Strengths & Weaknesses
7.10 AutoGenomics
  7.10.1 AutoGenomics Details
  7.10.2 AutoGenomics Major Business
  7.10.3 AutoGenomics Molecular Theranostics Product and Services
  7.10.4 AutoGenomics Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 AutoGenomics Recent Developments/Updates
  7.10.6 AutoGenomics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Molecular Theranostics Industry Chain
8.2 Molecular Theranostics Upstream Analysis
8.3 Molecular Theranostics Midstream Analysis
8.4 Molecular Theranostics Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Molecular Theranostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Theranostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Theranostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Theranostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Theranostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Theranostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Theranostics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Theranostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Theranostics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Theranostics Players in 2022
Table 12. World Molecular Theranostics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Theranostics Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Theranostics Player
Table 15. Molecular Theranostics Market: Company Product Type Footprint
Table 16. Molecular Theranostics Market: Company Product Application Footprint
Table 17. Molecular Theranostics Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Theranostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Theranostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Theranostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Theranostics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Theranostics Revenue Market Share (2018-2023)
Table 23. China Based Molecular Theranostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Theranostics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Theranostics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Theranostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Theranostics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Theranostics Revenue Market Share (2018-2023)
Table 29. World Molecular Theranostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Theranostics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Theranostics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Theranostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Theranostics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Theranostics Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Molecular Theranostics Product and Services
Table 38. Roche Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Molecular Theranostics Product and Services
Table 44. Abbott Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. BD Basic Information, Area Served and Competitors
Table 48. BD Major Business
Table 49. BD Molecular Theranostics Product and Services
Table 50. BD Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BD Recent Developments/Updates
Table 52. BD Competitive Strengths & Weaknesses
Table 53. Biomerieux Basic Information, Area Served and Competitors
Table 54. Biomerieux Major Business
Table 55. Biomerieux Molecular Theranostics Product and Services
Table 56. Biomerieux Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Biomerieux Recent Developments/Updates
Table 58. Biomerieux Competitive Strengths & Weaknesses
Table 59. Qiagen Basic Information, Area Served and Competitors
Table 60. Qiagen Major Business
Table 61. Qiagen Molecular Theranostics Product and Services
Table 62. Qiagen Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Qiagen Recent Developments/Updates
Table 64. Qiagen Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific Molecular Theranostics Product and Services
Table 68. Thermo Fisher Scientific Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Agilent Basic Information, Area Served and Competitors
Table 72. Agilent Major Business
Table 73. Agilent Molecular Theranostics Product and Services
Table 74. Agilent Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Agilent Recent Developments/Updates
Table 76. Agilent Competitive Strengths & Weaknesses
Table 77. GenMark Basic Information, Area Served and Competitors
Table 78. GenMark Major Business
Table 79. GenMark Molecular Theranostics Product and Services
Table 80. GenMark Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. GenMark Recent Developments/Updates
Table 82. GenMark Competitive Strengths & Weaknesses
Table 83. Siemens Healthcare Basic Information, Area Served and Competitors
Table 84. Siemens Healthcare Major Business
Table 85. Siemens Healthcare Molecular Theranostics Product and Services
Table 86. Siemens Healthcare Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Siemens Healthcare Recent Developments/Updates
Table 88. AutoGenomics Basic Information, Area Served and Competitors
Table 89. AutoGenomics Major Business
Table 90. AutoGenomics Molecular Theranostics Product and Services
Table 91. AutoGenomics Molecular Theranostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Molecular Theranostics Upstream (Raw Materials)
Table 93. Molecular Theranostics Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Theranostics Picture
Figure 2. World Molecular Theranostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Theranostics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Theranostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Theranostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Theranostics Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Theranostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Theranostics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Theranostics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Theranostics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Theranostics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Theranostics Markets in 2022
Figure 27. United States VS China: Molecular Theranostics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Theranostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Theranostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Theranostics Market Size Market Share by Type in 2022
Figure 31. Amplification Theranostics
Figure 32. Amplified Gene Detection Theranostics
Figure 33. Oligonucleotide Microarrays
Figure 34. Gene Sequencing
Figure 35. World Molecular Theranostics Market Size Market Share by Type (2018-2029)
Figure 36. World Molecular Theranostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Molecular Theranostics Market Size Market Share by Application in 2022
Figure 38. Hospitals and Clinics
Figure 39. Research Institutes
Figure 40. Diagnostic Centers
Figure 41. Others
Figure 42. Molecular Theranostics Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source